Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,429 public trials 1,038 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate

NCT03898128

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Irst Irccs Meldola (FC), FC, Italy
  • AUSL Romagna Ravenna, RA, Italy
  • Azienda ULSS2 Marca Trevigiana Treviso, TV, Italy
  • ULSS 3 Serenissima Mestre, Venezia, Italy
View Trial Details
Completed

A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT05687032

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Guangzhou First People's Hospital Guangzhou, Guangdong, China
  • NanFang Hospital of Southern Medical University Guangzhou, Guangdong, China
View all 16 locations
View Trial Details
Completed

Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients

NCT04008706

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Research Site Chandler, Arizona, United States
  • Research Site Long Beach, California, United States
  • Research Site Redlands, California, United States
  • Research Site Whittier, California, United States
View all 108 locations
View Trial Details
Completed

Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)

NCT04826523

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Pusan National University Hospital /ID# 239010 Busan, Busan Gwang Yeogsi, South Korea
  • Kosin University Gospel Hospital /ID# 257399 Busan, Busan Gwang Yeogsi, South Korea
  • Kyungpook National University Hospital /ID# 257398 Daegu, Daegu Gwang Yeogsi, South Korea
  • Gachon University Gil Medical Center /ID# 239008 Incheon, Gyeonggido, South Korea
View Trial Details
Completed

Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma

NCT02568553

Conditions
Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +53 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
View all 24 locations
View Trial Details
Completed

Study of Zanubrutinib in Japanese Participants With B-Cell Malignancies

NCT04172246

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +28 more
Locations
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Toyohashi Municipal Hospital Toyohashishi, Aichi-ken, Japan
  • Chiba Cancer Center Chiba, Japan
  • Matsuyama Red Cross Hospital Matsuyama, Ehime, Japan
View all 15 locations
View Trial Details
Completed

Veliparib and Temozolomide in Treating Patients With Acute Leukemia

NCT01139970

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +45 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details

Related conditions